))
97: Luis Valente: Startup CEOs – Passion Over Glamour? [EN]
Manage episode 453349577 series 3381015
Indhold leveret af André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af André Correia e Daniel Guedelha, André Correia, and Daniel Guedelha eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In today's CRUZAMENTO Podcast, André Correia e Daniel Guedelha talked with Luis Valente, CEO of iLOF, a deep-tech health startup, who shared insights on revolutionising personalised medicine. iLOF leverages Optomics—an innovative combination of optical data and AI—to overcome challenges in clinical trials, such as invasive procedures and recruitment inefficiencies. Luis highlights the startup's impactful partnership in an ambitious Alzheimer's trial and reflects on the demanding, often misunderstood role of a startup CEO. He offers advice for transitioning from corporates to startups, emphasising stage-appropriate involvement and culture alignment. Success hinges on hiring motivated people, fostering purpose, and prioritising high-performing teams over micromanaging the unmotivated. 🚀
Luis Valente, CEO & Co-Founder @ iLoF Business manager, strategist, and entrepreneur with a drive for using innovative and creative strategies to solve complex problems. Forbes 30 under 30 for Science and Healthcare, with a background in Computer Science, I have spent several years focusing on innovation and improving strategies in companies from Tech to Healthcare. My passion for entrepreneurship led me to create my first business at 18, founding and operating several ventures specializing in optimized demand prediction, lean operations, and design for growth. A deep belief in the power of Technology as the core driver for democratizing Personalized Medicine had me co-founding iLoF: a fast-growing deep tech company using AI to build a cloud-based library of disease biomarkers and biological profiles. Currently on a mission to accelerate adequate treatments for millions of patients living with complex, heterogeneous diseases around the globe.
Other relevant references | Outras referências relevantes:
Contacts | Contactos:
- CruzamentoPodcast.com
- cruzamentopodcast@gmail.com
- LinkedIN: Cruzamento
- Twitter: @cruzamentofm
- Facebook: @podcastcruzamento
- Instagram: @cruzamentopodcast
- YouTube: Podcast Cruzamento
Episode edited by João Cunha Studios
98 episoder
Del
